These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15913039)
1. [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia]. Brajusković G; Orolicki SV; Cerović S; Usaj SK; Marjanović S; Romac S Vojnosanit Pregl; 2005 May; 62(5):357-63. PubMed ID: 15913039 [TBL] [Abstract][Full Text] [Related]
2. [Expression of the Bcl-2 family of proteins in peripheral blood B-lymphocytes in patients with chronic lymphocytic leukemia]. Brajusković G; Vukosavić S; Dimitrijević J; Cerović S; Usaj SK; Marjanović S; Romac S; Milić AS Vojnosanit Pregl; 2004; 61(1):41-6. PubMed ID: 15022388 [TBL] [Abstract][Full Text] [Related]
3. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients. Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768 [TBL] [Abstract][Full Text] [Related]
4. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 regulatory pathway is functional in chronic lymphocytic leukemia. Goolsby C; Paniagua M; Tallman M; Gartenhaus RB Cytometry B Clin Cytom; 2005 Jan; 63(1):36-46. PubMed ID: 15624202 [TBL] [Abstract][Full Text] [Related]
6. Fibronectin interaction with alpha4beta1 integrin prevents apoptosis in B cell chronic lymphocytic leukemia: correlation with Bcl-2 and Bax. de la Fuente MT; Casanova B; Garcia-Gila M; Silva A; Garcia-Pardo A Leukemia; 1999 Feb; 13(2):266-74. PubMed ID: 10025901 [TBL] [Abstract][Full Text] [Related]
7. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia. Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897 [TBL] [Abstract][Full Text] [Related]
8. Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia. Ghassemifar R; Forster L; Finlayson J; Calogero T; Augustson B; Joske D; Cull G Pathology; 2012 Dec; 44(7):632-7. PubMed ID: 23172082 [TBL] [Abstract][Full Text] [Related]
9. Drug-induced apoptosis in chronic lymphocytic leukemia. Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065 [TBL] [Abstract][Full Text] [Related]
10. Fludarabine induces apoptosis in chronic lymphocytic leukemia--the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins. Faria JR; Yamamoto M; Faria RM; Kerbauy J; Oliveira JS Braz J Med Biol Res; 2006 Mar; 39(3):327-33. PubMed ID: 16501812 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic. Ghiotto F; Fais F; Tenca C; Tomati V; Morabito F; Casciaro S; Mumot A; Zoppoli G; Ciccone E; Parodi S; Bruno S Cancer Biol Ther; 2009 Feb; 8(3):263-71. PubMed ID: 19164937 [TBL] [Abstract][Full Text] [Related]
13. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance. Bannerji R; Kitada S; Flinn IW; Pearson M; Young D; Reed JC; Byrd JC J Clin Oncol; 2003 Apr; 21(8):1466-71. PubMed ID: 12697868 [TBL] [Abstract][Full Text] [Related]
14. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Packham G; Stevenson FK Immunology; 2005 Apr; 114(4):441-9. PubMed ID: 15804279 [TBL] [Abstract][Full Text] [Related]
15. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia. Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352 [TBL] [Abstract][Full Text] [Related]
16. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells. Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286 [TBL] [Abstract][Full Text] [Related]
17. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796 [TBL] [Abstract][Full Text] [Related]
18. In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Gottardi D; Alfarano A; De Leo AM; Stacchini A; Aragno M; Rigo A; Veneri D; Zanotti R; Pizzolo G; Caligaris-Cappio F Br J Haematol; 1996 Sep; 94(4):612-8. PubMed ID: 8826882 [TBL] [Abstract][Full Text] [Related]
19. Targeting the apoptotic pathway with BCL-2 inhibitors sensitizes primary chronic lymphocytic leukemia cells to vesicular stomatitis virus-induced oncolysis. Tumilasci VF; Olière S; Nguyên TL; Shamy A; Bell J; Hiscott J J Virol; 2008 Sep; 82(17):8487-99. PubMed ID: 18579592 [TBL] [Abstract][Full Text] [Related]
20. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells. Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]